Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

ARRY 4.00 +0.03 (0.76%)
price chart
Is Array Biopharma Inc (ARRY) a Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings.
Trader's Round Up: Array Biopharma Inc(ARRY), Stanley Black & Decker ...  Investor Wired
Array Biopharma Incorporated (NASDAQ:ARRY) rerated by Analysts to Average of 1 ?  The Bulletin
Shares of Array BioPharma Inc. (NASDAQ:ARRY) Sees Large Inflow of Net Money Flow
Array BioPharma Inc. (NASDAQ:ARRY) witnessed a selling pressure and the shares last traded with a loss of -0.17 points or -4.1% at $3.86.
Array BioPharma Inc. Short Interest Update  News Watch International
Steady Biotech Moves: Great Basin Scientific Inc (NASDAQ:GBSN), Array ...  Wsnews4investors
Trade-Ideas: Array BioPharma (ARRY) Is Today's Weak On High Relative Volume Stock
The debt-to-equity ratio is very high at 4.51 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company.
Company Shares of Array BioPharma Inc. (NASDAQ:ARRY) Drops by -8.64%  American Trade Journal
Will Array BioPharma Inc. (NASDAQ:ARRY) Surprise This Quarter?  Investor Newswire
CFO Moves: Alcoa, Array BioPharma
Alcoa Inc., an aluminum company based in New York, said Chief Financial Officer William Oplinger will be CFO of its raw aluminum business upon the company's planned breakup in the second half of next year.
Array BioPharma's New CFO to Step Down After Just Three Months on the Job  PharmaLive (press release) (subscription)
Price Target Update on Array BioPharma Inc. (NASDAQ:ARRY)
Array BioPharma Inc. (NASDAQ:ARRY): 6 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $10.33 in Array BioPharma Inc. (NASDAQ:ARRY). However, the stock price could fluctuate by $ 2.5 from the estimate as it ...
3 biotech stocks are getting crushed: Array Biopharma Inc (NASDAQ:ARRY ...  Wall Street Point
Stock in Motion: Array BioPharma Inc. (NASDAQ:ARRY)  Vanguard Tribune
Array BioPharma's new CFO to resign after 3 months on job
The newly-appointed chief financial officer at Array BioPharma Inc. in Boulder will step down after three months on the job.
The Three Most Strong Buy Stocks: Array Biopharma Inc (NASDAQ:ARRY), Sabre ...
Array Biopharma Inc (NASDAQ:ARRY) gained 0.76% and closed in the last trading session at $4.00. The 52-Week range of the stock is $3.82 - $8.59.
Array Biopharma Inc (NASDAQ:ARRY) Hedge Fund Sentiment Trend
Array Biopharma Inc (NASDAQ:ARRY) hedge funds sentiment increased to 1.47 in Q2 2015. Its up 0.03, from 1.44 in 2015Q1. The sentiment has improved, as 84 investment managers increased and started new holdings, while 57 reduced and sold holdings ...
Array BioPharma Inc. Price Target Update  Insider Trading Report
Biotech Stocks to Love: Galena Biopharma (NASDAQ:GALE), Array Biopharma Inc ...  Wall Street Point
Array BioPharma And Pierre Fabre Announce Development And Commercialization ...
BOULDER, Colo., Nov. 16, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced a collaboration to globally develop and commercialize Array's late-stage novel oncology products, binimetinib and encorafenib.
Deal provides Array $35M upfront, up to $425M in milestone payments  BizWest Media
Short Interest Update on Array BioPharma Inc.
Array BioPharma Inc. (NASDAQ:ARRY) ensharesed a rise of 0.3% or 70,733 shares in the short positions. The number escalated from 28,322,569 on September 30,2015 to 28,393,302 on October 15,2015.